{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T09:08:40Z","timestamp":1717146520285},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/mjt.0b013e3180a5e7d6","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T07:02:37Z","timestamp":1190271757000},"page":"449-454","source":"Crossref","is-referenced-by-count":2,"title":["Limitations of Current Prophylaxis Against Influenza Virus Infection"],"prefix":"10.1097","volume":"14","author":[{"given":"Mario","family":"Guralnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A","family":"Rosenbloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P","family":"Petteruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"LeFante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210202","first-page":"317","article-title":"Avian flu and possible human pandemic.","volume":"43","author":"Lahariya","year":"2006","journal-title":"Indian Pediatr"},{"key":"R2-10-20210202","first-page":"753","article-title":"Avian influenza.","volume":"28","author":"Wu","year":"2005","journal-title":"Chang Gung Med J"},{"key":"R3-10-20210202","first-page":"4","article-title":"Avian influenza: a pandemic waiting to happen?","volume":"39","author":"Liu","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1378\/chest.129.1.156","article-title":"Avian influenza virus infections in humans.","volume":"129","author":"Wong","year":"2006","journal-title":"Chest"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3201\/eid1201.050826","article-title":"Influenza-associated deaths in tropical Singapore.","volume":"12","author":"Chow","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"Suppl","key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1097\/01.inf.0000188160.83709.b7","article-title":"Avian influenza: an omnipresent pandemic threat.","volume":"24","author":"Perez","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3201\/eid1201.050983","article-title":"Pandemic influenza threat and preparedness.","volume":"12","author":"Fauci","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R9-10-20210202","first-page":"88","article-title":"World Health Organization Writing Group. Non-pharmaceutical interventions for pandemic influenza, national and community measures.","volume":"12","author":"Bell","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1371\/journal.pmed.0030212","article-title":"Delaying the international spread of pandemic influenza.","volume":"3","author":"Cooper","year":"2006","journal-title":"PLoS Med"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3138\/cbmh.22.1.57","article-title":"Co-operation in all human endeavour: quarantine and immigrant disease vectors in the 1918-1919 influenza pandemic in Winnipeg.","volume":"22","author":"Jones","year":"2005","journal-title":"Can Bull Med Hist"},{"issue":"Suppl","key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.inf.0000144756.69887.f8","article-title":"Immunization against viral respiratory disease: a review.","volume":"23","author":"Greenberg","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1079\/AHR2005101","article-title":"Avian influenza virus: prospects for prevention and control by vaccination.","volume":"6","author":"Lee","year":"2005","journal-title":"Anim Health Res Rev"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<237::AID-RMV252>3.0.CO;2-G","article-title":"The development of live attenuated cold-adapted influenza virus vaccine for humans.","volume":"9","author":"Maassab","year":"1999","journal-title":"Rev Med Virol"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2004.02.031","article-title":"Current status of live attenuated influenza virus vaccine in the US.","volume":"103","author":"Belshe","year":"2004","journal-title":"Virus Res"},{"key":"R18-10-20210202","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults.","volume":"3","author":"Demicheli","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"R19-10-20210202","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0264-410X(99)00105-X","article-title":"Complications of influenza and benefits of vaccination.","volume":"17","author":"Nichol","year":"1999","journal-title":"Vaccine"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.01.00084301","article-title":"Influenza: vaccination and treatment.","volume":"17","author":"Stephenson","year":"2001","journal-title":"Eur Respir J"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00430-002-0145-y","article-title":"Conceptional considerations for a German influenza pandemic preparedness plan.","volume":"191","author":"Fock","year":"2002","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"R22-10-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review.","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"R23-10-20210202","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review.","volume":"366","author":"Jefferson","year":"2005","journal-title":"Lancet"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0966-842X(00)88942-8","article-title":"Understanding the mechanism of action of the anti-influenza virus drug amantadine [letter].","volume":"3","author":"Pinto","year":"1995","journal-title":"Trends Microbiol"},{"key":"R25-10-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(92)91239-Q","article-title":"The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers.","volume":"190","author":"Duff","year":"1992","journal-title":"Virology"},{"key":"R26-10-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(06)67970-1","article-title":"Antivirals for influenza in healthy adults: systematic review.","volume":"367","author":"Jefferson","year":"2006","journal-title":"Lancet"},{"key":"R27-10-20210202","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/502326","article-title":"Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.","volume":"25","author":"McGeer","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R28-10-20210202","first-page":"189","article-title":"Human infection by avian influenza A H5N1.","volume":"11","author":"Yuen","year":"2005","journal-title":"Hong Kong Med J"},{"key":"R29-10-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/156800505774912884","article-title":"Neuraminidase inhibitors as antiviral agents.","volume":"5","author":"Alymova","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"key":"R30-10-20210202","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7350","article-title":"Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.","volume":"7","author":"Turner","year":"2003","journal-title":"Health Technol Assess"},{"key":"R31-10-20210202","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2165\/00019053-200523110-00003","article-title":"Antiviral agents for influenza: a comparison of cost-effectiveness data.","volume":"23","author":"Lynd","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"R32-10-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00151829-200504020-00004","article-title":"Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance.","volume":"4","author":"McKimm-Breschkin","year":"2005","journal-title":"Treat Respir Med"},{"key":"R33-10-20210202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study.","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"R34-10-20210202","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ptr.1518","article-title":"Antiviral activities of medicinal herbs traditionally used in southern mainland China.","volume":"18","author":"Li","year":"2004","journal-title":"Phytother Res"},{"key":"R35-10-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-8741(01)00389-0","article-title":"Antiviral Chinese medicinal herbs against respiratory syncytial virus.","volume":"79","author":"Ma","year":"2002","journal-title":"J Ethnopharmacol"},{"key":"R36-10-20210202","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus.","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res"},{"key":"R37-10-20210202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/10408399709527797","article-title":"The chemistry of tea flavonoids.","volume":"37","author":"Balentine","year":"1997","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R38-10-20210202","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1348-0421.2002.tb02724.x","article-title":"Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells.","volume":"46","author":"Imanishi","year":"2002","journal-title":"Microbiol Immunol"},{"key":"R39-10-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-3542(02)00212-7","article-title":"Inhibition of adenovirus infection and adenain by green tea catechins.","volume":"58","author":"Weber","year":"2003","journal-title":"Antiviral Res"},{"key":"R40-10-20210202","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0006-291X(03)00067-6","article-title":"Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate.","volume":"301","author":"Chang","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-10-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/095632020201300403","article-title":"Antiviral properties of prodelphinidin B-2 3-O-gallate from green tea leaf.","volume":"13","author":"Cheng","year":"2002","journal-title":"Antivir Chem Chemother"},{"key":"R42-10-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/acm.2005.11.49","article-title":"The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study.","volume":"11","author":"Lau","year":"2005","journal-title":"J Altern Complement Med"},{"key":"R43-10-20210202","first-page":"65","article-title":"Efficacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold.","volume":"22","author":"Scaglione","year":"1996","journal-title":"Drugs Exp Clin Res"},{"key":"R44-10-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/acm.2006.12.171","article-title":"Chinese medicinal herbs for influenza: a systematic review.","volume":"12","author":"Chen","year":"2006","journal-title":"J Altern Complement Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3180a5e7d6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:01Z","timestamp":1620963241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200709000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3180a5e7d6","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}